Cargando…

Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment

BACKGROUND: Despite the widespread availability of naloxone, US opioid overdose rates continue to rise. The “Cascade of Care” (CoC) is a public health approach that identifies steps in achieving specific outcomes and has been used to identify gaps in naloxone carriage among individuals with opioid u...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozak, Zofia, Ciccarone, Daniel, Thrul, Johannes, Cole, Thomas O., Pappas, Alexander L., Greenblatt, Aaron D., Welsh, Christopher, Yoon, Mark, Gann, Donald, Artigiani, E. Erin, Wish, Eric D., Belcher, Annabelle M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928141/
https://www.ncbi.nlm.nih.gov/pubmed/36788601
http://dx.doi.org/10.1186/s12954-023-00745-6
_version_ 1784888595124846592
author Kozak, Zofia
Ciccarone, Daniel
Thrul, Johannes
Cole, Thomas O.
Pappas, Alexander L.
Greenblatt, Aaron D.
Welsh, Christopher
Yoon, Mark
Gann, Donald
Artigiani, E. Erin
Wish, Eric D.
Belcher, Annabelle M.
author_facet Kozak, Zofia
Ciccarone, Daniel
Thrul, Johannes
Cole, Thomas O.
Pappas, Alexander L.
Greenblatt, Aaron D.
Welsh, Christopher
Yoon, Mark
Gann, Donald
Artigiani, E. Erin
Wish, Eric D.
Belcher, Annabelle M.
author_sort Kozak, Zofia
collection PubMed
description BACKGROUND: Despite the widespread availability of naloxone, US opioid overdose rates continue to rise. The “Cascade of Care” (CoC) is a public health approach that identifies steps in achieving specific outcomes and has been used to identify gaps in naloxone carriage among individuals with opioid use disorder (OUD). We sought to apply this framework to a treatment-seeking population with OUD that may be more inclined to engage in harm reduction behaviors. METHODS: Patients were recruited from an urban methadone program to complete a survey. We assessed naloxone familiarity, availability, obtainability, training, and possession, as well as naloxone carriage rates, demographics, and harm reduction behaviors. A multivariable logistic regression examined associations between naloxone carriage and individual-level factors. RESULTS: Participants (n = 97) were majority male (59%), with a mean age of 48 (SD = 12), 27% had college education or higher, 64% indicated injection drug use, and 84% reported past naloxone training. All participants endorsed familiarity with naloxone, but only 42% regularly carried naloxone. The following variables were associated with carrying naloxone: White race (aOR = 2.94, 95% CI 1.02–8.52), college education (aOR = 8.11, 95% CI 1.76–37.47), and total number of self-reported harm reduction behaviors (aOR = 1.45, 95% CI 1.00–2.11). CONCLUSION: We found low rates of naloxone carriage among methadone-treated patients. Methadone programs provide opportunities for naloxone interventions and should target racial/ethnic minorities and individuals with lower education. The spectrum of harm reduction behaviors should be encouraged among these populations to enhance naloxone carriage.
format Online
Article
Text
id pubmed-9928141
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99281412023-02-15 Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment Kozak, Zofia Ciccarone, Daniel Thrul, Johannes Cole, Thomas O. Pappas, Alexander L. Greenblatt, Aaron D. Welsh, Christopher Yoon, Mark Gann, Donald Artigiani, E. Erin Wish, Eric D. Belcher, Annabelle M. Harm Reduct J Brief Report BACKGROUND: Despite the widespread availability of naloxone, US opioid overdose rates continue to rise. The “Cascade of Care” (CoC) is a public health approach that identifies steps in achieving specific outcomes and has been used to identify gaps in naloxone carriage among individuals with opioid use disorder (OUD). We sought to apply this framework to a treatment-seeking population with OUD that may be more inclined to engage in harm reduction behaviors. METHODS: Patients were recruited from an urban methadone program to complete a survey. We assessed naloxone familiarity, availability, obtainability, training, and possession, as well as naloxone carriage rates, demographics, and harm reduction behaviors. A multivariable logistic regression examined associations between naloxone carriage and individual-level factors. RESULTS: Participants (n = 97) were majority male (59%), with a mean age of 48 (SD = 12), 27% had college education or higher, 64% indicated injection drug use, and 84% reported past naloxone training. All participants endorsed familiarity with naloxone, but only 42% regularly carried naloxone. The following variables were associated with carrying naloxone: White race (aOR = 2.94, 95% CI 1.02–8.52), college education (aOR = 8.11, 95% CI 1.76–37.47), and total number of self-reported harm reduction behaviors (aOR = 1.45, 95% CI 1.00–2.11). CONCLUSION: We found low rates of naloxone carriage among methadone-treated patients. Methadone programs provide opportunities for naloxone interventions and should target racial/ethnic minorities and individuals with lower education. The spectrum of harm reduction behaviors should be encouraged among these populations to enhance naloxone carriage. BioMed Central 2023-02-14 /pmc/articles/PMC9928141/ /pubmed/36788601 http://dx.doi.org/10.1186/s12954-023-00745-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Brief Report
Kozak, Zofia
Ciccarone, Daniel
Thrul, Johannes
Cole, Thomas O.
Pappas, Alexander L.
Greenblatt, Aaron D.
Welsh, Christopher
Yoon, Mark
Gann, Donald
Artigiani, E. Erin
Wish, Eric D.
Belcher, Annabelle M.
Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
title Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
title_full Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
title_fullStr Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
title_full_unstemmed Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
title_short Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
title_sort harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928141/
https://www.ncbi.nlm.nih.gov/pubmed/36788601
http://dx.doi.org/10.1186/s12954-023-00745-6
work_keys_str_mv AT kozakzofia harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT ciccaronedaniel harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT thruljohannes harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT colethomaso harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT pappasalexanderl harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT greenblattaarond harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT welshchristopher harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT yoonmark harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT ganndonald harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT artigianieerin harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT wishericd harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment
AT belcherannabellem harmreductionbehaviorsareassociatedwithcarryingnaloxoneamongpatientsonmethadonetreatment